Immune Regulation
Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune system for long-term remission.
Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune system for long-term remission.
Immune Regulation has raised $52.2M across 1 round. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Immune Regulation is featured in
Similar companies
Novellusdx develops tumor specific driver mutations.
Uniphy is an electronic company that enables intuitive free-form Touch Interfaces that are beautiful, robust and economic.
Sentinel is a wellness firm offering trauma prevention and management through their application and scientific expertise.
AI that changes how $700B hard facilities management industry handles repairs
StirlingX is a technology company that provides AI-driven data intelligence and autonomous drone solutions.
HubBox is shaping the future of shipping with best-in-class ‘pickup at checkout’ technology
Overstone Art is a financial services company.
We help businesses innovate, from the small things that can make a big difference to more-involved 'Eureka!' projects.
Monq is an AI-powered procurement negotiation platform for enterprises.
Ponda is a material science company that makes planet-positive textiles.
Neuracore is a robot learning platform that helps to train robots and deploy intelligent behaviour.
Cruden is a construction groups working in housing, commercial, leisure, health, retail and education sector.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.